The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the potential.

"This enhanced understanding of the regulation of spermatogenesis provides the foundation for further studies including ...

Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second ...

Report Ocean is a leading provider of in-depth market research reports, analyzing over 150 countries’ markets. With a focus on accuracy, their team of expert researchers and pro ...

Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff.. Around 95% ...

With stem cell treatments, ischemic stroke patients have shown improvement in motor function. Swiss Medica’s stem cell therapy and research Swiss Medica, a leading stem cell clinic , is at the ...

Discover LumiSTAR, a Taiwan biotech leader combining iPSC technology and patented bioimaging (LumiRDT) to revolutionize drug discovery and cell therapy platforms. News Home Page ...

Stem cell therapy is shaping up to be a game-changer in acne scar treatment. From boosting collagen to enhancing other treatments, stem cells offer a powerful new option for those who’ve ...

JCR announced that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene therapy research programs at ASGCT 2025.

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living with the condition. Skip to Article Set weather ...